Time (months) | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Time points | T0 | Â | T1 | Â | T2 | Â | T3 | ||||||
Primary outcomes | |||||||||||||
 New PU* |  | X | X | X | X | X | X | X | X | X | X | X | X |
 Picture | X | X | X | X | X | X | X | X | X | X | X | X | |
Secondary outcomes: PU risk factors | |||||||||||||
 Blood flow | X |  | X |  | X |  | X | ||||||
 Muscle thickness | X | X | X | X | |||||||||
 Interface pressure distribution | X | X | X | X | |||||||||
Secondary outcomes: Questionnaires | |||||||||||||
 PASPID | X |  | X |  | X |  | X | ||||||
 WHO-QoL-5 | X | X | X | X | |||||||||
 USER-participation | X | X | X | X | |||||||||
 SIP-68 | X | X | X | X | |||||||||
 HADS | X | X | X | X | |||||||||
 PSQI | X | X | X | X | |||||||||
 FSS | X | X | X | X | |||||||||
 Self-care capacity | X | X | X | X | |||||||||
Usability and user-friendliness of the ES system | |||||||||||||
 Self-administrated questionnaire |  |  | X |  | X |  | X |  | X | ||||
 Diary | X | X | X | X | X | X | X | X | X | X | X | X | |
Cost analysis | |||||||||||||
 EQ-5D-5L | X |  | X |  | X |  | X |  | X | ||||
 Online cost questionnaire | X | X | X | X | X | ||||||||
Process evaluation | |||||||||||||
 Questions of the RE-AIM model |  | X |  | X | |||||||||
 Interviews | X | X | |||||||||||
 Focus group |  | X |